ISDA

Deposition Date 2016-08-02

Release Date 2016-09-28

Last Version Date 2024-10-30

Entry Detail

PDB ID:

5L30

Keywords:

Hydrolase/Hydrolase Inhibitor

Title:

Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1H-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Cricetinae

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.73 Å

R-Value Free:

0.19

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII (Heavy Chain)
Gene (Uniprot):F7
Chain IDs:A (auth: H)
Chain Length:254
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII (Light Chain)
Gene (Uniprot):F7
Chain IDs:B (auth: L)
Chain Length:58
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Ligand Molecules

70A

GOL

SO4

Primary Citation

Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.

Ladziata, V.U, Glunz, P.W, Zou, Y, Zhang, X, Jiang, W, Jacutin-Porte, S, Cheney, D.L, Wei, A, Luettgen, J.M, Harper, T.M, Wong, P.C, Seiffert, D, Wexler, R.R, Priestley, E.S.Show

Bioorg.Med.Chem.Lett. 26 5051 5057 (2016)

PMID: 27612545 DOI: 10.1016/j.bmcl.2016.08.088

Abstact

Selective tissue factor-factor VIIa complex (TF-FVIIa) inhibitors are viewed as promising compounds for treating thrombotic disease. In this contribution, we describe multifaceted exploratory SAR studies of S1'-binding moieties within a macrocyclic chemotype aimed at replacing cyclopropyl sulfone P1' group. Over the course of the optimization efforts, the 1-(1H-tetrazol-5-yl)cyclopropane P1' substituent emerged as an improved alternative, offering increased metabolic stability and lower clearance, while maintaining excellent potency and selectivity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures